Trial Search Results

Greenlight Plus Study: Approaches to Early Childhood Obesity Prevention

A randomized controlled trial enrolling 900 parent-infant dyads (English and Spanish speaking) comparing Greenlight (control), a behavioral intervention focusing on nutrition, physical activity, media use, and sleep as compared to Greenlight Plus (intervention) which includes the above materials plus a health information technology (HIT) intervention aimed at supporting family goal-setting and behavior change during well-child checks throughout the first 2 years of life.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Vanderbilt University Medical Center

Collaborator: University of Miami

Stanford Investigator(s):

Intervention(s):

  • Behavioral: Greenlight Plus
  • Behavioral: Greenlight

Phase:

N/A

Eligibility


Inclusion Criteria:

For this study, eligible caregiver/infant dyads will be those with:

   1. an English- or Spanish-speaking parent/legal guardian,

   2. infant born in the newborn nursery with plans to have care in the local clinic OR
   presenting in that clinic for the first newborn visit (1-14 days of life),

   3. attendance at first newborn clinic visit

   4. no plans to leave the clinic within 2 years

   5. Completion of baseline data collection (survey data, child weight and length measures
   prior to randomization).

   6. Own a smartphone with access to data services

Exclusion Criteria:

Infant exclusion criteria:

   1. born prior to 34 weeks gestation or birth weight <1500 grams; weight <3rd %tile at
   enrollment (World Health Organization growth curves); or

   2. any chronic medical problem that may affect weight gain (e.g., metabolic disease,
   uncorrected congenital heart disease, renal disease, high-calorie formula; cleft
   palate; Down syndrome).

Caregiver exclusion criteria include:

   1. <18 years old;

   2. serious mental or neurologic illness that impairs ability to consent/participate;

   3. poor visual acuity (corrected vision worse than 20/50 with Rosenbaum Screener).

Ages Eligible for Study

N/A - 14 Days

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting